14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 CNTA stock ended at $9.25. This is 2.32% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 2.81% from a day low at $9.24 to a day high of $9.50.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Centessa Pharmaceuticals Limited prices

Date Open High Low Close Volume
Jun 13, 2023 $4.64 $4.75 $4.61 $4.68 118 973
Jun 12, 2023 $4.83 $4.83 $4.50 $4.64 61 954
Jun 09, 2023 $4.61 $4.80 $4.53 $4.61 123 705
Jun 08, 2023 $4.62 $4.71 $4.53 $4.61 74 903
Jun 07, 2023 $4.59 $4.66 $4.51 $4.64 104 161
Jun 06, 2023 $4.55 $4.74 $4.46 $4.65 184 210
Jun 05, 2023 $4.51 $4.53 $4.35 $4.46 91 695
Jun 02, 2023 $4.73 $4.76 $4.30 $4.50 156 691
Jun 01, 2023 $4.53 $4.69 $4.34 $4.66 53 859
May 31, 2023 $4.48 $4.59 $4.37 $4.51 28 719
May 30, 2023 $4.50 $4.60 $4.32 $4.57 29 452
May 26, 2023 $4.36 $4.45 $4.11 $4.32 23 746
May 25, 2023 $4.38 $4.59 $3.96 $4.29 76 415
May 24, 2023 $4.44 $4.65 $4.42 $4.57 175 395
May 23, 2023 $4.75 $4.78 $4.47 $4.47 195 415
May 22, 2023 $4.95 $4.95 $4.51 $4.72 300 045
May 19, 2023 $4.57 $4.64 $4.30 $4.59 39 844
May 18, 2023 $4.75 $4.75 $4.40 $4.40 136 599
May 17, 2023 $4.54 $4.71 $4.48 $4.67 71 531
May 16, 2023 $4.42 $4.74 $4.38 $4.47 148 534
May 15, 2023 $4.68 $4.99 $4.53 $4.64 154 755
May 12, 2023 $4.56 $4.70 $4.39 $4.65 98 928
May 11, 2023 $4.67 $4.83 $4.48 $4.63 183 486
May 10, 2023 $4.66 $4.84 $4.46 $4.62 465 490
May 09, 2023 $4.42 $4.71 $4.39 $4.67 39 507
Click to get the best stock tips daily for free!

About Centessa Pharmaceuticals Limited

Centessa Pharmaceuticals Limited Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; and SerpinPC, an activated protein C inhibitor, which is in Phase IIa clinical development for the treatm... CNTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT